Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV001526880 | SCV001737569 | likely pathogenic | Polycystic kidney disease 2 | 2021-06-21 | criteria provided, single submitter | clinical testing | The variant c.773T>C (p.(Leu258Pro)) in exon 3 of the PKD2-gene is not found in the gnomAD database and it affects a highly conserved nucleotide a moderately conserved amino acid within a protein domain and there is a moderate physicochemical difference between Leu and Pro. This variant has a pathogenic computational verdict based on 11 pathogenic predictions from BayesDel_addAF, DANN, DEOGEN2, EIGEN, FATHMM-MKL, LIST-S2, M-CAP, MutationAssessor, MutationTaster, PolyPhen-2 and SIFT vs 2 benign predictions from MVP and PrimateAI. This variant was found in an affected individual and his affected mother in our clinic, thus we classify this variant as a likely pathogenic mutation. ACMG criteria used for classification: PM2, PP1, PP2, PP3, PP4. |
Gene |
RCV003232373 | SCV003929657 | uncertain significance | not provided | 2022-12-02 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Institute of Human Genetics, |
RCV001526880 | SCV002035329 | uncertain significance | Polycystic kidney disease 2 | no assertion criteria provided | clinical testing |